LOW-CSD MELANOMA

Clinical trials for LOW-CSD MELANOMA explained in plain language.

Never miss a new study

Get alerted when new LOW-CSD MELANOMA trials appear

Sign up with your email to follow new studies for LOW-CSD MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug trial aims to extend life for advanced melanoma patients

Disease control Ongoing

This study is testing an experimental drug called dinaciclib in people with stage IV melanoma that has spread. The main goal is to see if the treatment helps patients live at least one year longer. Researchers will also monitor how well it controls the cancer's growth and what si…

Matched conditions: LOW-CSD MELANOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

LOW-CSD MELANOMA

Get alerted when new LOW-CSD MELANOMA trials appear

New drug trial aims to extend life for advanced melanoma patients